EHDS II – HealthData@EU

  • Zehn neue TEHDAS2-Leitlinien verfügbar

    Zehn neue TEHDAS2-Leitlinien verfügbar

    TEHDAS2 – die Joint Action von Mitgliedstaaten und EU-Kommission zur Vorbereitung der Einzelheiten der EHDS-Umsetzung – hat mit der Veröffentlichung einer Reihe neuer Leitlinien und technischer Spezifikationen einen weiteren Meilenstein erreicht. Diese Ergebnisse spiegeln die umfassende Zusammenarbeit zwischen den Mitgliedstaaten und der EU-Kommission wider und bauen auf den Rückmeldungen aus den öffentlichen Konsultationen auf.

    Gleichzeitig läuft noch die dritte und letzte öffentliche Konsultation. Noch eingehende Rückmeldungen werden die noch ausstehenden Durchführungs-Verordnungen (Implementing Regulations) im Sinne der einheitlichen Gestaltung des Europäischen Gesundheitsdatenraums (EHDS) unterstützen.

    Die TEHDAS2-Abschlusskonferenz ist dann für November 2026 geplant.

    (die folgenden HInweise wurden von der TEHDAS-Website übernommen)

    D4.1 Guideline for health data access bodies on fees and penalties for non-compliance related to the EHDS regulation  Read the guideline  
    TEHDAS2 has published guidance to help health data access bodies (HDABs) organise data access fees and oversee compliance under the European Health Data Space (EHDS).The document provides a practical reference for Member States preparing for national implementation and early operational activities.
    D5.2 Guideline for health data access bodies on minimum categories and limitations on the reuse of health data  Read the guideline  
    TEHDAS2 has published a new guideline to help health data access bodies (HDABs) assess whether a request for data is allowed, prohibited or subject to limitations under the European Health Data Space (EHDS).
    D6.1 Guideline for health data holders on making personal and non-personal electronic health data available for reuse  Read the guideline  
     TEHDAS2 has released a guideline for health data holders on making electronic health data available for secondary use under the European Health Data Space (EHDS). The document focuses on what happens after a national health data access body issues a data permit or approves a request. It places the role of health data holders (e.g. healthcare providers, registries, insurers and developers of health-related services and devices) within the wider EHDS framework and explains the main obligations and practical considerations for timely, consistent delivery.
    D6.3 Guideline for health data access bodies on the procedures and formats for data access  Read the guideline  
    A new TEHDAS2 guideline supports health data access bodies (HDABs) in processing data access applications and requests for the secondary use of electronic health data under the European Health Data Space (EHDS).
    The document outlines how HDABs can process both requests for anonymised statistical data and applications for access to individual-level data through secure processing environments (SPEs), covering the full lifecycle from receipt and pre-screening to decision-making and follow-up.
    D6.4 Data Access Application Management System (DAAMS) – Technical specification for health data access bodies  Read the specification  
    A new TEHDAS2 expert specification gives Member States a practical framework for building systems to handle health data access applications and requests under the European Health Data Space (EHDS).
    The document sets out how to develop a Data Access Application Management System (DAAMS), a national platform designed to support secure and compliant access to electronic health data for secondary use. It is intended to help health data access bodies (HDABs) manage applications and requests for purposes such as research, innovation and policymaking.
    It defines the technical and functional requirements for DAAMS and covers the full lifecycle of applications, from submission and evaluation to decision-making. Core features include application tracking, structured assessment and permit handling.
    D7.2 Guideline for health data access bodies on data minimisation, pseudonymisation, anonymisation and synthetic data  Read the guideline  
    A new TEHDAS2 guideline explains how health data can be safely accessed and used under the European Health Data Space (EHDS). It provides practical guidance on data minimisation and privacy-preserving methods throughout the data access process for those involved in the secondary use of sensitive health data.
    Intended for health data access bodies (HDABs), data holders and data users, the document explains at what level of detail and under which safeguards data can be accessed under the EHDS.
    It supports decision-making across the full user journey, from data access applications to analysis and the export of results. At the same time, it enables research, innovation and policymaking while helping to ensure that access decisions remain proportionate, and privacy risks are controlled.
    D7.3 Technical specification for health data access bodies on the implementation of the common IT infrastructure  Read the specification  
    TEHDAS2 has published a technical specification explaining how Member States can connect to HealthData@EU, the EU infrastructure for secondary use of health data under the European Health Data Space (EHDS).
    The document is intended for health data access bodies (HDABs) and national authorities preparing for EHDS implementation. It focuses on the common technical components and interfaces used to link national systems with HealthData@EU, enabling structured and interoperable information exchange between countries.
    Connecting to HealthData@EU in practice: The HealthData@EU infrastructure serves as the digital backbone connecting National Contact Points with the HealthData@EU Central Platform. This distributed architecture ensures a balanced governance model: the European Commission operates the central core, while Member States implement and maintain their national components.
    The specification describes how national components interact with the HealthData@EU Central Platform operated by the European Commission, outlining the main technical elements, operational roles and division of responsibilities between Member States and the EU.
     D7.4 Technical specification for health data access bodies on the implementation of secure processing environments  Read the specification  
    TEHDAS2 has published technical specifications defining how secure processing environments (SPEs) required under the European Health Data Space (EHDS) should be designed, operated and governed. The document provides health data access bodies (HDABs) with a common basis for implementing SPEs for the secondary use of electronic health data.
    The document outlines the minimum technical, functional and security capabilities that SPEs must offer. Under the EHDS, HDABs must grant access to data exclusively through controlled environments that enforce strict safeguards for confidentiality and security. These SPEs may be offered as a service from outside the HDAB organisation.
    A high-level framework for implementation: The specification sets out minimum requirements for SPEs and the capabilities needed to protect sensitive data while enabling scientific research. It provides a common reference for implementation across national settings. It also defines baseline interoperability requirements for SPE-based federations, supporting data processing across organisations and Member States. The document is intended to inform follow-on technical guidance, standardisation work and the European Commission’s implementing acts. In doing so, it emphasises the value of a consistent approach to SPEs across Member States as a basis for trust.
    D8.1 Guideline for health data access bodies on implementing opt-out from the secondary use of health data  Read the guideline  
     TEHDAS2 has published a guideline to support health data access bodies in implementing the European Health Data Space (EHDS) opt-out right for secondary use of electronic health data. The guideline outlines key requirements for managing opt-out choices and where Member States have flexibility in organising technical and operational arrangements. 
    The document provides practical guidance on how individuals should be informed about the opt-out, how their choices can be recorded and managed, and how those choices should be respected when health data is made available for purposes such as research, innovation and policymaking. It also outlines the respective roles of health data access bodies, data holders and supervisory authorities in supporting implementation.  
    D8.2 Guideline for health data access bodies on implementing the obligation of notifying the natural person on a significant finding from the secondary use of health data  Read the guideline  
    TEHDAS2 has published a guideline for health data access bodies on handling significant findings arising from the secondary use of electronic health data under the European Health Data Space (EHDS). It sets out how such findings should be managed securely, transparently and in line with national rules. 
    The guideline makes clear that health data access bodies are not responsible for clinical validation or for contacting individuals directly. Their role is to receive notifications from authorised data users and securely forward the information to the relevant health data holder, while clinical assessment and decisions on whether and how to inform a person remain within national frameworks. 
      These and previously published guidelines can be explored on the Results page of tehdas.eu in two complementary ways: by user group or by phase of the EHDS user journey.
  • TEHDAS2 Konsultationen (3. Runde) zu Details der Sekundärnutzung von Gesundheitsdaten

    TEHDAS2 Konsultationen (3. Runde) zu Details der Sekundärnutzung von Gesundheitsdaten

    Im Rahmen der Joint Action TEHDAS2 der EU und ihrer Mitgliedsstaaten findet die dritte und letzte Runde von europaweiten Konsultationen statt. Dabei geht es um sieben Entwürfe zu Vorgaben und Empfehlungen für die Umsetzung der EHDS-Verordnung vom 11. Februar 2025 im Bereich der Sekundärnutzung von Gesundheitsdaten. Die enthaltenen Verfahren und Empfehlungen sind für verschiedene Aspekte dieser Nutzung relevant. Auf deren Grundlage wird die EU-Kommission bis März 2027 Durchführungsrechtsakte (Implementing Acts) erlassen. Das Kommentierungsverfahren richtet sich an alle Stakeholder und läuft vom 5. Mai bis zum 28. Juni 2026.
    Die betreffenden Dokumente sind unten verlinkt. Über den Button „Feedback geben” wird das jeweilige Feedbackverfahren erreicht.

    Leitseite TEHDAS2-Konsultationen | TMF-Webinarreihe zu TEHDAS Konsultationen

    1. Draft Guideline on a framework for collaboration
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    2. Draft Guideline for health data access bodies on international and third country access and transfer of electronic health data
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    3. Draft Guideline for data enrichment 
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    4. Draft Guideline for data users navigating the catalogue
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    5. Draft Guideline on linkage of health datasets
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    6. Draft guideline for health data access bodies on informing natural persons about the use of health data – “Citizen Information Point”
    Entwurf technische Spezifkation (download PDF) | Feedback geben (Umfragetool)

    7. Draft guideline for data users on handling research outcomes
    Entwurfsfassung der Guideline (download PDF) | Feedback geben (Umfragetool)

    (weitere Dokumente werden noch in dieser Liste ergänzt)

  • Skepsis zum EHDS: Viele EU-Bürger würden Daten nicht mit Ärzten im Ausland teilen

    Skepsis zum EHDS: Viele EU-Bürger würden Daten nicht mit Ärzten im Ausland teilen

    Laut einer Umfrage von BEUC (Europäischer Verbraucherverband) lehnen viele Bürgerinnen und Bürger der Europäischen Union es ab, Ihre Gesundheitsdaten mit Ärzten im Ausland zu teilen. Die repräsentative Umfrage in acht EU-Ländern, darunter Deutschland, zeigt deutliche Unterschiede dahingehend auf, welche Daten welchen Institutionen preisgegeben würden.

    • Die Mehrheit (61 Prozent) der Befragten habe beispielsweise kein Problem damit, allgemeine Informationen zum Gesundheitszustand, unter anderem zu Allergien und Krankheiten, zu teilen.
    • Knapp 70 Prozent wollen laut Umfrage aber keine Auskunft über Gewohnheiten wie Ernährung, Bewegung und Drogenkonsum geben. Genetische Daten oder Angaben zur sexuellen Gesundheit will kaum jemand teilen.
    • Die Bereitschaft, Daten zu teilen, hänge auch stark von Vertrauen ab: Ihrem Hausarzt würden 88 Prozent der Befragten ihre Daten anvertrauen, ihrer Versicherung nur 8 Prozent.

    Hintergrund der Arbeit ist der Verordungsentwurf der EU-Kommission für den Europäischen Gesundheitsdatenraum (European Health Data Space – EHDS)“: Patienten könnten ihre Krankengeschichte, Testergebnisse oder Verschreibungen dann mit Krankenhäusern und Ärzten in der gesamten EU teilen. Europaparlament und die EU-Staaten müssen noch einen Kompromiss aushandeln.

    Ein Arzt in Frankreich könne dann etwa die Krankengeschichte eines Portugiesen einsehen, der in Paris krank wird, und die richtigen Medikamente verschreiben, sagte EU-Gesundheitskommissarin Stella Kyriakides vor genau einem Jahr. Unnötige Untersuchungen würden überflüssig. Das zweite Ziel des Vorschlags ist, dass Forscher, Industrie und öffentliche Institutionen das Potenzial der Daten nutzen können.

    BEUC-Studie: Download des Ergebnisberichts

    Executive summary: With the European Union institutions currently working to create a European health data space, which would allow the access and sharing of people’s health data across the EU, nine consumer organisations from eight EU countries have surveyed people to get a better insight on what they think about sharing their health data.

    This survey sheds light on consumer attitudes and unveils what type of data they are willing to share, with whom and for what purpose (for provision of healthcare, for scientific research, or for public health reasons).

    • Our survey reveals that consumers are generally cautious about sharing their health data through online health platforms and want to decide for themselves what data they share and with whom.
    • Health data is rightly regarded as both extremely sensitive and of great value by all kinds of entities, from public health authorities and businesses to people themselves.
    • As a result, it is crucial that EU legislators respect consumers’ interests, and our evidence-based recommendations should provide food for thought at this critical juncture.
  • TEHDAS study: Member states to harmonise national legislation to enable the secondary use of health data

    TEHDAS study: Member states to harmonise national legislation to enable the secondary use of health data

    Differing interpretations of the data protection regulation hinder the use of health data at the expense of health research, policymaking and innovation. TEHDAS has developed recommendations for member states to develop legislation on the secondary use of health data.

    The recent report of the joint action Towards the European Health Data Space (TEHDAS) urges EU member states to harmonise national provisions on data protection and consider abolishing national derogations on the General Data Protection Regulation (GDPR). The report also provides recommendations on drafting national legislation on the secondary use of health data that can expedite the realisation of the European health data space (EHDS) when it enters into force.

    Currently, countries have national legislation or rules on the use of health data for secondary purposes in addition to the GDPR. The GDPR provides a harmonised approach to data protection across the EU, but it allows member states to adopt national legislation which causes a lack of harmonisation. TEHDAS has previously concluded that the main obstacle for the cross-border use of health data for research, innovation and policymaking is differing interpretations of the law.

    The report presents nine recommendations for the member states on planning and implementing national legislation to regulate the secondary use of health data to complement the European health data space. They include choosing public interest as the legal basis for collecting health data, addressing security by design to avoid problems in practice when using data, and ensuring proper financial and human resources for processing data access applications and preparing data for its users.

    There are also aspects of national laws that are specifically relevant to consider concerning the cross-border sharing of health data, for instance data security legislation prohibiting the transfer of data out of the country. Member states should consider harmonising such regulation.

    Furthermore, a general recommendation for facilitating cross-border sharing of health data would be necessary to avoid divergent national regulations, since this is one of the main reasons that the full potential of sharing data cross-border has not yet been realised.

    Because the negotiations on the EHDS proposal are ongoing, TEHDAS hopes that the member states can benefit from the recommendations as they plan their national legislation on the secondary use of health data. This could smooth the transition to European health data space.

    The report is based on a study conducted in six European countries.

    TEHDAS Report laden (TEHDAS WP5.2 Deliverable)

    Joint Action Towards the European Health Data Space – TEHDAS

    The TEHDAS Joint Action develops European principles for the secondary use of health data. TEHDAS is being carried out by 25 European countries and co-ordinated by the Finnish Innovation Fund, Sitra. The project started in February 2021. It is based on the European Commission’s Health Programme 2020.

    TEHDAS Factsheet

  • HealthData@EU Pilot launches Proof of Concept

    HealthData@EU Pilot launches Proof of Concept

    Launched in October 2022, the HealthData@EU Pilot project reached a first milestone by framing the scope and activities that will be performed during the Proof Of Concept (PoC) phase. The framing phase saw the drafting of a first high-level vision of the target architecture and defining an organisational framework to implement an EHDS solution. Starting in March 2023, the PoC phase aims to deliver and deploy a Minimum Viable Product (MVP) at the end of 2023 enabling the two first steps of the user journey :

    The target MVP expected for December 2023, will focus on connecting three nodes (France, Denmark and Finland) and the European Central Services by setting up an eDelivery network. This MVP network will be used to centralize national dataset catalogues to the European one and to forward data permit requests from central services to the three nodes.

    eDelivery network (Europe, Denmark, Finland, France), Source: https://www.ehds2pilot.eu/

    A first high level vision of the target architecture

    The design of the target solution has been driven by three main guidelines : (1) build a scalable and distributed network that can easily onboard new nodes or host a new technical use cases, (2) leverage open source technologies and (3) propose a security- oriented solution. The infrastructure for each node comprises a cross-border gateway in charge of eDelivery communication with other nodes, a national
    connector that provides all necessary features to fulfill the needs of the user journey steps to the nodes and crossborder engines that translate existing national capabilities of the nodes to a crossborder standard.

    An iterative approach to deliver the Minimum Viable Product (MVP)

    The full specifications of the solution are strongly dependent to tasks performed by work packages 6 and 7 and won’t be provided at the beginning of the POC phase (i.e. definition of the metadata standards or definition of the information that needs to be provided by an applicant during a Data Permit process). In order to parallelise tasks, the implementation of the solution will be done incrementally, by delivering multiple functional versions of the solution. We plan to deliver three product increments before December 2023, each one being an improvement to the prior version.

    Impementations planning. Source: https://www.ehds2pilot.eu/

    EHDS2Pilot Work Package 5 „Proof of Concept“ information and planning document.

    About the EHDS2 HealthData@EU Pilot project

    The EHDS2 Pilot HealthData@EU project brings together national data permit authorities, public health infrastructures and health research infrastructures, in order to enable linking and integrating data between data sources. This pilot project is a major first step that will allow practical validation of this concept i.e. the access to health data in Europe. 

    The EHDS2 Pilot project is very important because it taps into the wealth of health data which today is fragmented across Europe and research has difficulty to access this data for science.

    Press release announcing the launch of EHDS2Pilot incl. list of partners

    EHDS2Pilot Cross-border use cases
    Work packages for building the technical infrastructure